Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

homeHome
play_circleCurrent Issuecheck_circleAccepted ManuscriptslistAll Issuesformat_indent_increaseIn Press ArticlessearchSearch
helpInstructions
infoJournal InformationgroupsBoards and committeesshareIndexing and Listing Sourcesshow_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementmenu_bookReviewer and AE Registration FormemailSupportphoneContact Us
format_list_bulletedAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. Assessment of the Prevalence of Non-Organ-Specific Autoantibodies in Egyptian Patients with HCV

- Emara M. , et al.

2. Verification of B-lymphocyte activating factor's involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver disease

- Himoto T. , et al.

3. The presence of autoantibodies to cytoplasmic rod and ring particles in the serum of patients with chronic hepatitis C virus infection

- Afsharzadeh F. , et al.

4. The prevalence of autoantibody and its relationship with genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection

- Kirdar S. , et al.

5. Activation-induced cytidine deaminase is dispensable for virus-mediated liver and skin tumor development in mouse models

- Nguyen T. , et al.

6. Relationship between autoimmunity and cancer or metabolic abnormality in liver diseases

- Himoto T. , et al.

7. Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis

- Himoto T. , et al.

8. Prevalence and impact of chronic hepatitis C virus infection on the clinical manifestations and disease activity among patients suffering from systemic lupus erythematosus

- El Garf A. , et al.

9. Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection

- Himoto T. , et al.

10. Clinical relevance of antibodies to cardiolipin in patients with chronic hepatitis c

- Himoto T. , et al.

11. Autoantibodies in patients with chronic hepatitis C virus infection: Pitfalls for the diagnosis of rheumatic diseases

- Palazzi C. , et al.

12. Anti-IFN autoantibodies are present in healthy Egyptian blood donors at low titer

- Ibrahim E. , et al.

13. Hepatitis c virus as a multifaceted disease: A simple and updated approach for extrahepatic manifestations of hepatitis c virus infection

- Khattab M.A. , et al.